Report Detail
COVID-19 Impact on Global Antipsychotic Medications Market Insights, Forecast to 2026
- RnM3985272 |
- 03 June, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antipsychotic Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antipsychotic Medications industry.
Based on our recent survey, we have several different scenarios about the Antipsychotic Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antipsychotic Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antipsychotic Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antipsychotic Medications market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Antipsychotic Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Antipsychotic Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Antipsychotic Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Antipsychotic Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antipsychotic Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antipsychotic Medications market.
The following manufacturers are covered in this report:
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Antipsychotic Medications Breakdown Data by Type
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants (TCAs)
Monoamine Oxidase Inhibitors (MAOIs)
Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
Tetracyclic Antidepressants (TeCAs)
Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
Antipsychotic Medications Breakdown Data by Application
Hospital Pharmacies
Drug Stores
Others
1 Study Coverage
- 1.1 Antipsychotic Medications Product Introduction
- 1.2 Market Segments
- 1.3 Key Antipsychotic Medications Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Antipsychotic Medications Market Size Growth Rate by Type
- 1.4.2 Selective Serotonin Reuptake Inhibitors (SSRIs)
- 1.4.3 Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- 1.4.4 Tricyclic Antidepressants (TCAs)
- 1.4.5 Monoamine Oxidase Inhibitors (MAOIs)
- 1.4.6 Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
- 1.4.7 Tetracyclic Antidepressants (TeCAs)
- 1.4.8 Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
- 1.5 Market by Application
- 1.5.1 Global Antipsychotic Medications Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Drug Stores
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Antipsychotic Medications Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Antipsychotic Medications Industry
- 1.6.1.1 Antipsychotic Medications Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Antipsychotic Medications Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Antipsychotic Medications Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Antipsychotic Medications Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Antipsychotic Medications Market Size Estimates and Forecasts
- 2.1.1 Global Antipsychotic Medications Revenue 2015-2026
- 2.1.2 Global Antipsychotic Medications Sales 2015-2026
- 2.2 Antipsychotic Medications Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Antipsychotic Medications Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Antipsychotic Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antipsychotic Medications Competitor Landscape by Players
- 3.1 Antipsychotic Medications Sales by Manufacturers
- 3.1.1 Antipsychotic Medications Sales by Manufacturers (2015-2020)
- 3.1.2 Antipsychotic Medications Sales Market Share by Manufacturers (2015-2020)
- 3.2 Antipsychotic Medications Revenue by Manufacturers
- 3.2.1 Antipsychotic Medications Revenue by Manufacturers (2015-2020)
- 3.2.2 Antipsychotic Medications Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Antipsychotic Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Antipsychotic Medications Revenue in 2019
- 3.2.5 Global Antipsychotic Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Antipsychotic Medications Price by Manufacturers
- 3.4 Antipsychotic Medications Manufacturing Base Distribution, Product Types
- 3.4.1 Antipsychotic Medications Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antipsychotic Medications Product Type
- 3.4.3 Date of International Manufacturers Enter into Antipsychotic Medications Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Antipsychotic Medications Market Size by Type (2015-2020)
- 4.1.1 Global Antipsychotic Medications Sales by Type (2015-2020)
- 4.1.2 Global Antipsychotic Medications Revenue by Type (2015-2020)
- 4.1.3 Antipsychotic Medications Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Antipsychotic Medications Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Antipsychotic Medications Sales Forecast by Type (2021-2026)
- 4.2.2 Global Antipsychotic Medications Revenue Forecast by Type (2021-2026)
- 4.2.3 Antipsychotic Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Antipsychotic Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Antipsychotic Medications Market Size by Application (2015-2020)
- 5.1.1 Global Antipsychotic Medications Sales by Application (2015-2020)
- 5.1.2 Global Antipsychotic Medications Revenue by Application (2015-2020)
- 5.1.3 Antipsychotic Medications Price by Application (2015-2020)
- 5.2 Antipsychotic Medications Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Antipsychotic Medications Sales Forecast by Application (2021-2026)
- 5.2.2 Global Antipsychotic Medications Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Antipsychotic Medications Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Antipsychotic Medications by Country
- 6.1.1 North America Antipsychotic Medications Sales by Country
- 6.1.2 North America Antipsychotic Medications Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Antipsychotic Medications Market Facts & Figures by Type
- 6.3 North America Antipsychotic Medications Market Facts & Figures by Application
7 Europe
- 7.1 Europe Antipsychotic Medications by Country
- 7.1.1 Europe Antipsychotic Medications Sales by Country
- 7.1.2 Europe Antipsychotic Medications Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antipsychotic Medications Market Facts & Figures by Type
- 7.3 Europe Antipsychotic Medications Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Antipsychotic Medications by Region
- 8.1.1 Asia Pacific Antipsychotic Medications Sales by Region
- 8.1.2 Asia Pacific Antipsychotic Medications Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Antipsychotic Medications Market Facts & Figures by Type
- 8.3 Asia Pacific Antipsychotic Medications Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Antipsychotic Medications by Country
- 9.1.1 Latin America Antipsychotic Medications Sales by Country
- 9.1.2 Latin America Antipsychotic Medications Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Antipsychotic Medications Market Facts & Figures by Type
- 9.3 Central & South America Antipsychotic Medications Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Antipsychotic Medications by Country
- 10.1.1 Middle East and Africa Antipsychotic Medications Sales by Country
- 10.1.2 Middle East and Africa Antipsychotic Medications Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Antipsychotic Medications Market Facts & Figures by Type
- 10.3 Middle East and Africa Antipsychotic Medications Market Facts & Figures by Application
11 Company Profiles
- 11.1 Johnson and Johnson
- 11.1.1 Johnson and Johnson Corporation Information
- 11.1.2 Johnson and Johnson Description, Business Overview and Total Revenue
- 11.1.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Johnson and Johnson Antipsychotic Medications Products Offered
- 11.1.5 Johnson and Johnson Recent Development
- 11.2 Eli Lilly
- 11.2.1 Eli Lilly Corporation Information
- 11.2.2 Eli Lilly Description, Business Overview and Total Revenue
- 11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Eli Lilly Antipsychotic Medications Products Offered
- 11.2.5 Eli Lilly Recent Development
- 11.3 Bristol-Myers Squibb
- 11.3.1 Bristol-Myers Squibb Corporation Information
- 11.3.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bristol-Myers Squibb Antipsychotic Medications Products Offered
- 11.3.5 Bristol-Myers Squibb Recent Development
- 11.4 AstraZeneca
- 11.4.1 AstraZeneca Corporation Information
- 11.4.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 AstraZeneca Antipsychotic Medications Products Offered
- 11.4.5 AstraZeneca Recent Development
- 11.5 Novartis
- 11.5.1 Novartis Corporation Information
- 11.5.2 Novartis Description, Business Overview and Total Revenue
- 11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Novartis Antipsychotic Medications Products Offered
- 11.5.5 Novartis Recent Development
- 11.6 Allergan
- 11.6.1 Allergan Corporation Information
- 11.6.2 Allergan Description, Business Overview and Total Revenue
- 11.6.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Allergan Antipsychotic Medications Products Offered
- 11.6.5 Allergan Recent Development
- 11.7 Pfizer
- 11.7.1 Pfizer Corporation Information
- 11.7.2 Pfizer Description, Business Overview and Total Revenue
- 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Pfizer Antipsychotic Medications Products Offered
- 11.7.5 Pfizer Recent Development
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Corporation Information
- 11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 GlaxoSmithKline Antipsychotic Medications Products Offered
- 11.8.5 GlaxoSmithKline Recent Development
- 11.1 Johnson and Johnson
- 11.1.1 Johnson and Johnson Corporation Information
- 11.1.2 Johnson and Johnson Description, Business Overview and Total Revenue
- 11.1.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Johnson and Johnson Antipsychotic Medications Products Offered
- 11.1.5 Johnson and Johnson Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Antipsychotic Medications Market Estimates and Projections by Region
- 12.1.1 Global Antipsychotic Medications Sales Forecast by Regions 2021-2026
- 12.1.2 Global Antipsychotic Medications Revenue Forecast by Regions 2021-2026
- 12.2 North America Antipsychotic Medications Market Size Forecast (2021-2026)
- 12.2.1 North America: Antipsychotic Medications Sales Forecast (2021-2026)
- 12.2.2 North America: Antipsychotic Medications Revenue Forecast (2021-2026)
- 12.2.3 North America: Antipsychotic Medications Market Size Forecast by Country (2021-2026)
- 12.3 Europe Antipsychotic Medications Market Size Forecast (2021-2026)
- 12.3.1 Europe: Antipsychotic Medications Sales Forecast (2021-2026)
- 12.3.2 Europe: Antipsychotic Medications Revenue Forecast (2021-2026)
- 12.3.3 Europe: Antipsychotic Medications Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Antipsychotic Medications Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Antipsychotic Medications Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Antipsychotic Medications Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Antipsychotic Medications Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Antipsychotic Medications Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Antipsychotic Medications Sales Forecast (2021-2026)
- 12.5.2 Latin America: Antipsychotic Medications Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Antipsychotic Medications Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Antipsychotic Medications Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Antipsychotic Medications Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Antipsychotic Medications Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Antipsychotic Medications Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Antipsychotic Medications Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antipsychotic Medications Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Antipsychotic Medications. Industry analysis & Market Report on COVID-19 Impact on Global Antipsychotic Medications is a syndicated market report, published as COVID-19 Impact on Global Antipsychotic Medications Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Antipsychotic Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
